Pharma News

Mylan N.V. (NASDAQ: MYL) announced the U.S. Federal Trade Commission ("FTC") has cleared the company's proposed transaction to acquire Perrigo Company plc (NYSE: PRGO; TASE) subject to Mylan's divestiture of certain products following the consummation of the offer. The FTC clearance represents the final regulatory clearance needed by Mylan to close its acquisition of Perrigo and represents the last remaining condition that needs to be satisfied for the successful completion of the offer other than the acceptance condition.

Bayer CropScience has reached an important milestone towards the market introduction of its innovative insecticide Sivanto Prime in Europe. Its active ingredient flupyradifurone, which belongs to the chemical class of butenolides, has been approved for the maximum time span of 10 years by the European Commission in accordance with Regulation (EC) 1107/2009.  The first national registrations of Sivanto prime in European countries are expected in 2016 and the market introduction is planned for 2017.

Boehringer Ingelheim announced at the BIO-Europe® conference in Munich, Germany, the initiation of a global Phase II trial evaluating the efficacy and safety of BI 1482694 (HM61713) in patients with T790M mutation-positive non-small cell lung cancer (NSCLC), whose tumours stopped responding to currently available epidermal growth factor receptor (EGFR) directed therapies. The primary endpoint of this trial, which is the first in a broad clinical development programme for BI 1482694, is objective response rate (ORR).

[adsense:336x280:8701650588]

Nestle India said the "masala" version of Maggi noodles will hit the retail shelves as early as this month, having cleared all the tests ordered by the Bombay High Court at three accredited laboratories.

(BWI); Biocon Ltd has earned the distinction of being the only Asian Biopharma Company to feature among the top biotechnology employers in the world as ranked by Science magazine. The ranking is a result of a global survey conducted by the American Association for the Advancement of Science (AAAS) through its affiliate Science magazine to determine which companies in the biotech and pharmaceutical industry have the best reputations as employers globally.

(BWI); Anand Diagnostic Lab, one of India‘s oldest and leading, stand-alone diagnostic services company, launched a new drive-through blood collection service that will help customers reduce the time and effort required to give samples for required tests.

Sanofi and BioNTech announced that they have entered into a multiyear exclusive collaboration and license agreement. This research collaboration between Sanofi and BioNTech will leverage the scientific expertise of the two organizations to discover and develop up to five cancer immunotherapies, each consisting of a mixture of synthetic messenger RNAs (mRNAs).

Cow & Gate, a baby food company is recalling a batch of its 'Sunny Start My First Banana Muesli' packs after receiving complaints of insects found in it.

The INSPIRE consortium, led by Videregen Ltd, has received approval from the MHRA to start a UK clinical trial with its tissue engineered replacement trachea. The trial, which is expected to start in the first half of 2016, will focus on severe structural airway disease (SSAD), a potentially life-threatening condition believed to affect 19,000 people in Europe and the US.  Along with Videregen as commercial partner, the consortium includes the Cell Therapy Catapult, University College London (UCL), NHS Blood and Transplant in Speke and the Royal Free London NHS Foundation Trust.

Nearly half of the children in the slums of the eastern metropolis are underweight, a survey said on Tuesday, drawing attention to the dismal nutrition scenario in urban slums.